Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Kalaris Therapeutics, Inc. (KLRS)
Activity window: Sep. 29, 2025 to Sep. 28, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 9, 2026 | CORRESP | Neutral/Informational | High | Kalaris Therapeutics, Inc. has submitted a request for acceleration of the effective date of its Registration Statement on Form S-3, which was filed on April 3, 2026. The company … | Read Filing EDGAR |
| Apr. 9, 2026 | CORRESP | Neutral/Informational | Moderate | Kalaris Therapeutics, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-3, which was filed on April 3, 2026. The comp… | Read Filing EDGAR |
| Apr. 8, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Kalaris Therapeutics, Inc. that they will not review the company's registration statement filed on April 3, 2026. The letter emphasizes the company's r… | Read Filing EDGAR |
| Apr. 8, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has formally notified Kalaris Therapeutics, Inc. that it will not review their registration statement filed on April 3, 2026. The letter emphasizes the company's responsib… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.